Peripheral Arterial Disease Intermittent claudication
Conditions
Interventions
Data collection will be performed through two evaluations: initial and after eight weeks of supervised training, which will occur with a weekly frequency of three times. The initial anamnesis will be
b) ISWT and Treadmill test in a random order with constant velocity associated with gas analysis. Between the application of the tests will be applied the WIQ. The tests will follow the same order of
Other
G11.427.410.698.277
E02.331.800
Sponsors
Universidade Federal de Minas Gerais
Faculdade de Ciências Médicas e da Saúde de Juiz de Fora - SUPREMA
Eligibility
Inclusion criteria
Inclusion criteria: To be included he must initially sign the free and informed consent form. There may be no claudicating pain of non-vascular origin; uncontrolled diabetes; uncontrolled hypertension; chronic kidney disease diagnosed; acute myocardial infarction in the last three months; history of recent pulmonary embolism; neuromuscular changes that limit the functional capacity; exercise tolerance primarily limited by factors other than the claudicating symptom and cardiovascular physical therapy in the last three months.
Exclusion criteria
Exclusion criteria: Individuals unable to understand and perform procedures with the measurement is with higher blood pressure (BP) values superior to 200 / 110 mmHg and heart rate (HR) greater than 120 bpm; and HR > 85% of maximal predicted by age during exercise testing.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluate the time to the beginning of the pain; distance traveled until initial pain; maximum pain time; total distance and resting time required to disappear the symptoms in the functional capacity test called the incremental shuttle walking test It is expected to find reduction of the initial pain, maximum pain time, total distance and rest time necessary to disappear the claudicating symptoms in the group of participants submitted to transcutaneous electrical nerve stimulation when compared to the group that was submitted only to conventional treatment (walking training) associated with placebo;Evaluate the time to the beginning of the pain; distance traveled until initial pain; maximum pain time; total distance and resting time required to disappear the symptoms in the functional capacity test called the treadmill test. It is expected to find reduction of the initial pain, maximum pain time, total distance and rest time necessary to disappear the claudicating symptoms in the group of participants submitted to transcutaneous electrical nerve stimulation when compared to the group that was submitted only to conventional treatment (walking training) associated with placebo | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluate the peak VO2; peak heart rate; arterial blood pressure and double product in the constant velocity treadmill test and autonomic cardiovascular function through the variability of heart rate and cardiac vagal index It is expected to find reduction of peak VO2; arterial blood pressure; peak heart rate and double product in the treadmill test at constant speed in the group of participants submitted to transcutaneous electrical nerve stimulation when compared to the group that was submitted only to conventional treatment (walking training ) associated with placebo. It is expected to find an improvement in the cardiovascular autonomic function measured by the heart rate variability test and a 4-second test in the group of participants submitted to transcutaneous electrical nerve stimulation when compared to the group that was submitted only to the conventional treatment (associated walking training) to placebo | — |
Countries
Brazil
Contacts
Public ContactAna Ferreira
Faculdade de Ciências Médicas e da Saúde de Juiz de Fora - SUPREMA
Outcome results
None listed